IL-2 and antigen dose differentially regulate perforin- and FasL-mediated cytolytic activity in antigen specific CD4+ T cells

被引:95
作者
Brown, Deborah M. [1 ]
Kamperschroer, Cris [1 ]
Dilzer, Allison M. [1 ]
Roberts, Deborah M. [1 ]
Swain, Susan L. [1 ]
机构
[1] Trudeau Inst Inc, Saranac Lake, NY 12983 USA
关键词
CD4; subsets; Cytotoxicity; Peptide dose; IL-2; Perforin; IN-VIVO; TRANSCRIPTION FACTOR; GENE-EXPRESSION; SECRETING TH1; CUTTING EDGE; NAIVE CD4(+); PROTECTION; EFFECTOR; INFLUENZA; IMMUNITY;
D O I
10.1016/j.cellimm.2009.03.002
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
CD4 T cell effectors can promote survival against lethal influenza virus via perforin mediated cytolytic mechanisms; however, our understanding of how naive CD4 cells differentiate into class 11 restricted killers remains obscure. To address this, TCR Tg CD4 cells were activated in vitro and examined for their ability to lyse target cells. We found that cytokine polarized CD4 T cell effectors displayed cytolytic activity with the hierarchy Th0 > Th1 > Th2. Further, IL-4 inhibited the generation of cytotoxic CD4 cells. LPS stimulated B cells and bone marrow derived dendritic cells (BMDC) both induced potent cytolytic activity; however, IL-6, TGF-beta, IL-10, IL-12 or TNF-alpha were not required for inducing cytollytic activity in CD4 effectors. Antigen dose had a marked effect on cytotoxicity: low concentrations of peptide induced more potent cytolytic activity than relatively high concentrations. At low peptide concentration, exogenous IL-2 was necessary to drive granzyme B (GrB) expression and perforin mediated lysis. Thus, low antigen dose and early activation signals via IL-2 direct the CD4 T cell response toward effectors with perforin mediated cytolytic potential. These data have implications for the design of vaccines that may induce cytolytic CD4 cells in vivo and improve cell-mediated immunity to viral and bacterial infections. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:69 / 79
页数:11
相关论文
共 70 条
[11]   Migration kinetics and final destination of type 1 and type 2 CD8 effector cells predict protection against pulmonary virus infection [J].
Cerwenka, A ;
Morgan, TM ;
Harmsen, AG ;
Dutton, RW .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (02) :423-434
[12]  
CHEN WF, 1991, J IMMUNOL, V147, P528
[13]   EXTENT OF T-CELL RECEPTOR LIGATION CAN DETERMINE THE FUNCTIONAL-DIFFERENTIATION OF NAIVE CD4(+) T-CELLS [J].
CONSTANT, S ;
PFEIFFER, C ;
WOODARD, A ;
PASQUALINI, T ;
BOTTOMLY, K .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (05) :1591-1596
[14]   IL-10: The master regulator of immunity to infection [J].
Couper, Kevin N. ;
Blount, Daniel G. ;
Riley, Eleanor M. .
JOURNAL OF IMMUNOLOGY, 2008, 180 (09) :5771-5777
[15]  
Curtsinger JM, 1999, J IMMUNOL, V162, P3256
[16]   Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major [J].
Darrah, Patricia A. ;
Patel, Dipti T. ;
De Luca, Paula M. ;
Lindsay, Ross W. B. ;
Davey, Dylan F. ;
Flynn, Barbara J. ;
Hoff, Soren T. ;
Andersen, Peter ;
Reed, Steven G. ;
Morris, Sheldon L. ;
Roederer, Mario ;
Seder, Robert A. .
NATURE MEDICINE, 2007, 13 (07) :843-850
[17]   A subset of toll-like receptor ligands induces cross-presentation by bone marrow-derived dendritic cells [J].
Datta, SK ;
Redecke, V ;
Prilliman, KR ;
Takabayashi, K ;
Corr, M ;
Tallant, T ;
DiDonato, J ;
Dziarski, R ;
Akira, S ;
Schoenberger, SP ;
Raz, E .
JOURNAL OF IMMUNOLOGY, 2003, 170 (08) :4102-4110
[18]   Interleukin-10 promotes the maintenance of antitumor CD8+ T-cell effector function in situ [J].
Fujii, S ;
Shimizu, K ;
Shimizu, T ;
Lotze, MT .
BLOOD, 2001, 98 (07) :2143-2151
[19]   Cutting edge:: Contact-mediated suppression by CD4+-CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism [J].
Gondek, DC ;
Lu, LF ;
Quezada, SA ;
Sakaguchi, S ;
Noelle, RJ .
JOURNAL OF IMMUNOLOGY, 2005, 174 (04) :1783-1786
[20]   INFLUENZA VIRUS-SPECIFIC CD4+ T-HELPER TYPE-2 T-LYMPHOCYTES DO NOT PROMOTE RECOVERY FROM EXPERIMENTAL VIRUS-INFECTION [J].
GRAHAM, MB ;
BRACIALE, VL ;
BRACIALE, TJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (04) :1273-1282